Song, X., Niu, J. (2025). Anti-CD7 CAR T-cell therapy for ultra-high-risk relapsed/refractory T-ALL/lbl: Insights into lineage switch and consolidation strategies. Blood. https://doi.org/10.1182/blood-2025-4156